Document is current
Any future updates will be listed below
-
Authors
Delgado, Diego
Dabbous, Firas
Shivappa, Nitin
Mazhar, Faizan
Wittbrodt, Eric
Shridharmurthy, Divya
Järbrink, Krister
-
Funding
Funding for this research was provided by:
AstraZeneca United States (AstraZeneca United States)
- License Information
-
More Information
Article History
Received: 9 May 2024
Accepted: 7 January 2025
First Online: 16 January 2025
Declarations
:
: Not applicable.
: Not applicable.
: FD, FM and DS are full-time employees of Evidera. DD received consulting fees and speakers’ honoraria from Akcea, Alnylam, Pfizer and AstraZeneca. NS, EW, and KJ are full-time employees of AstraZeneca and hold stock in the company.
